Operationalizing High-Sensitivity Cardiac Troponin Pathways - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Implementing High-Sensitivity Cardiac Troponin Testing Pathways

  • By

  • James S. Ford

  • William B. Stubblefield

  • Jesse O. Wrenn

  • November 10, 2026

Share

  • 1

    Across 4 urban EDs, an EHR-integrated hs-cTn pathway was associated with an approximately 30-minute decrease in ED length of stay for patients with chest pain who underwent troponin testing.

  • 2

    The pathway conditionally released serial orders, displayed pathway status and timing on shared track boards, and incorporated the final evaluation interpretation.

  • 3

    Earlier studies found ED length-of-stay changes after hs-cTn implementation ranging from a 60-minute decrease to a 10-minute increase, suggesting assay speed alone may not improve workflow.

  • 4

    The hs-cTn period had more serial troponin measurements and 30-day AMI diagnoses, but no corresponding increase in 30-day PCI or ED cardiology consultation.

  • 5

    The study’s pre-post design and multifaceted intervention limit causal attribution, and it did not assess patient-centered outcomes such as missed AMI, readmissions, or mortality.

Original Source(s)

Related Content